- Home
- » Tags
- » Tetrabenazine
Top View
- A Phase II Randomized, Double-Blind Placebo Controlled, Study Of
- Tetrabenazine | Memorial Sloan Kettering Cancer Center
- Hikma Launches Tetrabenazine Tablets
- Tetrabenazine
- Clinical Characteristics of Tetrabenazine-Induced Parkinsonism Deepal Shah, B.S
- Managing Movements
- Differential Effects of Monoamine Uptake Inhibitors on Effort-Related Choice Behavior
- Prtaro-CLOMIPRAMINE Clomipramine Hydrochloride Capsules, USP
- Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
- PRODUCT MONOGRAPH Prnitoman® Tetrabenazine 25Mg
- AUSTEDO the Following Day
- Medications for Huntington's Disease
- Utah Medicaid Pharmacy & Therapeutics Drug Class Review
- Product Monograph
- Drug Metabolism Test
- Llllllllllllllll a Guide to Tourette Syndrome Medications
- Neuroprotective Effects of Psychotropic Drugs in Huntington's
- Psychiatry Pharmacogenetic Genotyping Panel
- Drug Metabolism Test Name
- Tetrabenazine (Xenazine) Reference Number: CP.PHAR.92 Effective Date: 12.01.11 Last Review Date: 05.21 Line of Business: Commercial, HIM, Medicaid Revision Log
- 209241Orig1s000
- Austedo) Reference Number: CP.PHAR.341 Effective Date: 06.13.17 Last Review Date: 05.20 Line of Business: Commercial, HIM, Medicaid Revision Log
- Xenazine® (Tetrabenazine) Tablets
- Guidelines for the Administration of Drugs Through Enteral Feeding Tubes
- FDA Approved VMAT2 Inhibitors for the Treatment of Tardive Dyskinesia
- Membrane by Binding of [2-3H]Dihydrotetrabenazine (Adrenal Medulla/Catecholamine Uptake/Scatchard Analysis/Neuroleptics) D
- Xenazine Prescribing Information
- PRODUCT MONOGRAPH ELAVIL® Amitriptyline Hydrochloride Tablets USP 10, 25, 50 and 75 Mg Antidepressant AA PHARMA INC. DATE OF
- EFFECTS of MIANSERIN, a NEW ANTIDEPRESSANT, on the in Vitro and in Vivo UPTAKE of MONOAMINES 1
- [Product Monograph Template
- Manic-Depressive Illness
- Pharmacologic Characterization of Valbenazine (NBI-98854) and Its Metabolites
- The Management of Tics David Shprecher, DO, Roger Kurlan, MD
- Xenazine (Tetrabenazine)
- Summary of Product Characteristics 1 Name of the Medicinal Product
- Drug-Induced Movement Disorders